Immunoreactive surfactant protein-D (SP-D) was assessed in human fetal, newborn, and adult tissues. In the fetal lung, SP-D was detected on airway surfaces by 10 weeks' gestation, staining increasing in the distal airways, decreasing in the proximal conducting airways with advancing gestation. In lungs from near-term infants and adults, SP-D was detected in Type II cells, serous cells of tracheobronchial glands, and subsets of cells lining peripheral airways. Immunostaining was decreased or absent in areas of lungs of neonates after injury to Type II cells, infection, or hemorrhage and was decreased in collapsed or unseptated airways from older infants with bronchopulmonary dysplasia. SP-D was also detected in many organs at all ages. SP-D was readily detected in epithelial cells and luminal material in lacrimal glands, salivary glands, pancreas, bile ducts, renal tubules, esophageal muscle and glands, parietal cells of the stomach, crypts of Lieberkuhn, sebaceous and eccrine sweat glands, Von Ebner's glands, endocervical glands, seminal vesicles, adrenal cortex, myocardium, and anterior pituitary gland. SP-D is a widely distributed member of the "collectin" family of polypeptides secreted onto luminal surfaces by epithelial cells lining ducts of many organs, where it likely plays a role in innate host defense.

Download full-text PDF

Source
http://dx.doi.org/10.1177/002215540205000506DOI Listing

Publication Analysis

Top Keywords

sp-d detected
16
surfactant protein-d
8
protein-d sp-d
8
human fetal
8
fetal newborn
8
newborn adult
8
adult tissues
8
type cells
8
cells lining
8
epithelial cells
8

Similar Publications

Cohort study of serological biomarkers for interstitial lung disease in patients with rheumatoid arthritis.

Scand J Rheumatol

November 2024

Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.

Objective: Interstitial lung disease (ILD) is an important cause of mortality in patients with rheumatoid arthritis (RA). Early RA-ILD detection is essential to improve prognosis. Here, we investigated eight serological biomarkers that may contribute to RA-ILD detection.

View Article and Find Full Text PDF
Article Synopsis
  • Idiopathic pulmonary fibrosis (IPF) is a serious lung disease of unknown origin, and the study aims to explore specific biomarkers (KL-6, MMP-7, SP-A, SP-D, VEGF, and periostin) to aid in diagnosis and monitor treatment response in IPF patients.
  • The study involved 47 IPF patients, 27 with other interstitial lung diseases, and 21 healthy individuals, with various tests and serum samples taken for analysis.
  • Results show that while periostin and SP-A levels were higher in both IPF and non-IPF patients compared to healthy controls, only SP-A effectively distinguished IPF cases; certain biomarkers also correlated with lung function metrics in treated patients.
View Article and Find Full Text PDF

Given the various clinical manifestations that characterize Coronavirus Disease 2019 (COVID-19), the scientific community is constantly searching for biomarkers with prognostic value. Surfactant proteins A (SP-A) and D (SP-D) are collectins that play a crucial role in ensuring proper alveolar function and an alteration of their serum levels was reported in several pulmonary diseases characterized by Acute Respiratory Distress Syndrome (ARDS) and pulmonary fibrosis. Considering that such clinical manifestations can also occur during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, we wondered if these collectins could act as prognostic markers.

View Article and Find Full Text PDF

Progressive pulmonary fibrosis (PPF), defined as the worsening of various interstitial lung diseases (ILDs), currently lacks useful biomarkers. To identify novel biomarkers for early detection of patients at risk of PPF, we performed a proteomic analysis of serum extracellular vesicles (EVs). Notably, the identified candidate biomarkers were enriched for lung-derived proteins participating in fibrosis-related pathways.

View Article and Find Full Text PDF

Untargeted lipidomics of bronchopulmonary dysplasia induced by hyperoxia exposure in rats.

Transl Pediatr

May 2024

Division of Neonatology, Department of Pediatrics, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.

Article Synopsis
  • Bronchopulmonary dysplasia (BPD) is a major respiratory issue in premature infants, linked to impaired lung development and lipid metabolism, particularly involving surfactants like dipalmitoylphosphatidylcholine.
  • In a study, neonatal rats were exposed to high oxygen levels (hyperoxia) for 14 days, followed by analysis of lung tissue and lipid composition using advanced mass spectrometry techniques.
  • The results showed significant changes in lung structure and a reduction in important lipids, particularly triacylglycerol and phosphatidylcholine, suggesting potential targets for BPD therapies and biomarkers for research.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!